INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Walgreens Boots Alliance, Inc. and Certain Officers - WBA
Portfolio Pulse from
Pomerantz Law Firm has filed a class action lawsuit against Walgreens Boots Alliance (WBA) alleging widespread violations of the Controlled Substances Act and False Claims Act. The lawsuit stems from a DOJ complaint that Walgreens knowingly dispensed millions of unlawful prescriptions, particularly opioids, between 2012 and 2025. Following the DOJ announcement, WBA's stock price dropped 12.06%.
March 25, 2025 | 2:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
DOJ complaint and class action lawsuit expose Walgreens to potential massive financial penalties, regulatory scrutiny, and reputational harm related to opioid prescription practices.
The DOJ complaint and class action lawsuit directly target Walgreens' core business practices, alleging systematic violations of federal drug laws. This exposes the company to potential massive financial penalties, ongoing legal challenges, and significant reputational damage.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100